Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
HC Wainwright & Co. analyst Yi Chen maintains Axogen (NASDAQ:AXGN) with a Buy and raises the price target from $25 to $26.
Raymond James analyst Jayson Bedford maintains Axogen (NASDAQ:AXGN) with a Outperform and raises the price target from $20 t...
Canaccord Genuity analyst Caitlin Cronin maintains Axogen (NASDAQ:AXGN) with a Buy and raises the price target from $24 to $27.
Citizens analyst David Turkaly maintains Axogen (NASDAQ:AXGN) with a Market Outperform and raises the price target from $26 ...
Axogen (NASDAQ:AXGN) raises FY2025 sales outlook from $219.000 million to $222.800 million vs $219.719 million estimate.
Axogen (NASDAQ:AXGN) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $0.07 by 66.67...
